Abstract
Discovering lead compounds from complex natural matrices traditionally requires resource‐intensive isolation steps. Integrating computational biology with untargeted metabolomics offers a more efficient alternative for rapid target prediction and screening. Here, we present a computational pipeline combining LC–MS/MS metabolomics, network pharmacology, and molecular docking to identify bioactive scaffolds. We applied this approach to the methanolic extract of the Antarctic moss Chorisodontium aciphyllum as a model matrix. Profiling the bioactive fraction (Fr.3) identified 17 secondary metabolites, primarily featuring fatty acid and steroidal scaffolds. Network pharmacology and functional annotation predicted ERBB2 and AKT1 as key protein targets for anti‐lung cancer activity. Molecular docking supported these predictions, showing that steroidal and secosteroidal compounds such as 5α‐ergosta‐7,22‐diene‐3β,5‐diol and 25‐hydroxyvitamin D2 exhibit high binding affinities to these targets. As a preliminary in vitro validation of the computationally predicted pathways, we found that Fr.3 significantly increased intracellular reactive oxygen species (ROS) levels and induced apoptosis‐mediated cell death in LLC1 murine lung cancer cells (IC 50 ≈ 45.79 µg/mL). Our findings demonstrate that combining untargeted metabolomics with computational analysis can effectively streamline the discovery of therapeutic leads from uncharacterized natural extracts.
Funding Information
  • Ministry of Oceans and Fisheries (PE26150)
  • Ministry of Oceans and Fisheries (PE26220)

This publication has 52 references indexed in Scilit: